Real World Evidence: Priority Setting for Action

Real World Evidence: Presentations

Sunday, 2 November 2014
Toronto, Ontario

Opening and Opening Remarks

  • John Sproule, IHE
  • Lisa Marsden, VP of Market Access & Government Relations at AstraZeneca Canada
  • Vasanthi Srinivasan, Executive Director, Ontario SPOR DSU

PART I: Fit for purpose: When and where is real-world evidence most useful?

  • Speaker: Muhammad Mamdani, Director, Applied Health Research Centre, St. Michael's Hospital
    Download Presentation
  • Panelists:
    Cy Frank, President and CEO, Alberta Innovates Health Solutions
    Greg Zaric, Professor, Ivey Business School
    Elaine Campbell, President, AstraZeneca Canada Inc.

PART II: Guiding principles for its use: What questions do we need to consider?

  • Speaker: Neil Corner, Director, Innovative Solutions (Real World Evidence Lead) at IMS Brogan
    Download Presentation
  • Panelists:
    Deborah Marshall, Associate Professor, University of Calgary
    Robyn Tamblyn, Director, Canadian Institutes of Health Research – Institute for Health Services and Policy Research
    Carole McMahon, Patient representative expert, pan-Canadian Oncology Drug Review Expert Review Committee (pERC)

Directed discussion with first session panelists

PART III: Final Thoughts - data access, linkage and public perception of risk.

Moderated discussion with Invited Panelists

Summary of Discussion
Suzanne McGurn, ADM, Ontario MOHLTC

Closing Remarks – Next Steps